Rhoen-Klinikum AG

Factors to consider:

• Company pays dividends (annually): last record date 2026-05-29, amount 0.23$ (Y1.50%)
• Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [10.20$, 15.83$]
• 2025-12-31 to 2026-12-31 estimated range: [10.55$, 16.40$]

Financial Metrics affecting the RHKJF estimates:

• Positive: with PPE of 18.7 at the end of fiscal year the price was low
• Positive: Operating cash flow per share per price, % of 15.58 > 12.93
• Positive: -5.34 < Operating profit margin, % of 3.02
• Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.38
• Negative: Industry earnings per price (median), % of 0 <= 0
• Negative: Industry operating cash flow per share per price (median), % of 2.59 <= 5.50
• Positive: Inventory ratio change, % of 0.59 <= 0.80
• Negative: Industry operating profit margin (median), % of -3.22 <= 2.87
• Negative: 0.01 < Interest expense per share per price, % of 0.42
• Positive: Industry inventory ratio change (median), % of 0 <= 0